Antibody discovery companies develop platforms and services for identifying antibodies used in therapeutics, diagnostics and life science research. Their technologies support candidate discovery, screening, optimisation and early development.
This category includes companies working on:
Browse 45 UK antibody discovery companies below.
Medical research charity translating science into treatments and diagnostics
LifeArc is a self-funded UK medical research charity focused on translating early-stage science into treatments and diagnostics for patients with rare diseases and global health challenges. Formerly MRC Technology, the organisation operates its own drug discovery and diagnostics development laboratories in Stevenage…
Generative AI platform for T cell receptor and antibody therapeutics
Etcembly is a biotech company using generative AI to discover and engineer T cell receptor and antibody therapeutics. The company's platform applies large language models to TCR sequence data to design candidates with high affinity and selectivity for cancer and autoimmune disease targets. Its lead programme, ETC-101,…
Synthetic VHH antibody libraries and discovery services
Isogenica is a contract discovery company specialising in VHH single-domain antibody discovery, offering what it describes as the world's largest synthetic VHH library alongside its proprietary screening platform. The company partners with pharmaceutical and biotechnology companies to identify high-affinity antibody…
High-affinity sheep monoclonal antibodies for clinical diagnostic testing
Bioventix is a UK biotechnology company that creates, manufactures and supplies high-affinity sheep monoclonal antibodies for clinical diagnostic applications, particularly where conventional antibodies have failed to detect low-concentration or difficult targets. Its antibodies are supplied to major multinational in…
Inkjet microarray printing instruments and contract array services
Arrayjet is a manufacturer of inkjet-based microarray printing instruments and a provider of contract array research and manufacturing services. The company's patented non-contact dispensing platform prints proteins, antibodies, nucleic acids, and small molecules onto solid substrates for applications including…